Association Between Adaptive Servo-Ventilation Therapy and Renal Function

Cardio-renal syndrome is a challenging clinical entity to manage, and often associated with increased morbidity mortality. We hypothesized that adaptive servo-ventilation (ASV), non-invasive positive pressure ventilation ameliorates systemic/pulmonary congestion, may improve renal function in patients symptomatic heart failure complicated by the cardio-renal syndrome. Patients congestive who underwent ASV therapy for over 1 month were included this retrospective study. The trajectory of estimated glomerular filtration ratio (eGFR) between pre-1 period post-one-month (on ASV) compared. A total 81 (median 65 years old, men) included. eGFR decreased during from 52.7 (41.7, 64.6) down 49.9 (37.3, 63.5) mL/minute/1.73 m2 (P < 0.001) whereas we observed an increase following one-month up 53.4 (38.6, 68.6) = 0.022). reduction furosemide equivalent dose initiation was independently increases adjusted odds 13.72 (95% confidence interval 3.40-55.3, P 0.001). In conclusion, short-term preservation function, particularly when loop diuretics concomitantly reduced.